4.0
19 Aug 2015
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
New Company. Un Capped bonus potential. Stock options. Did not have the usual big pharma mentality. The company has the ability to make changes quickly due to it's small size.
Cons
Low starting salary at the time. Only one product to sell in 2013 - Vascepa. Large territories. No company cars so you put a lot of miles on your personal car.